INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$11.0M

$11,016,289

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Daniell Richard • Officer • EVP, Europe Commercial 10b5-1 SellΔOwn -16.8% 2026-03-05 $547,705 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Daniell Richard Officer • EVP, Europe Commercial 10b5-1 SellΔOwn -16.8%	2026-03-05	$547,705	S	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Daniell Richard • Officer • EVP, Europe Commercial 10b5-1 SellΔOwn -14.2% 2026-03-04 $2,983,517Largex3 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Daniell Richard Officer • EVP, Europe Commercial 10b5-1 SellΔOwn -14.2%	2026-03-04	$2,983,517Largex3	S	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Daniell Richard • Officer • EVP, Europe Commercial 10b5-1 SellΔOwn -35.1% 2026-03-03 $4,173,942Largex2 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Daniell Richard Officer • EVP, Europe Commercial 10b5-1 SellΔOwn -35.1%	2026-03-03	$4,173,942Largex2	S	Form 4
TEVA M TEVA PHARMACEUTICAL INDUSTRIES LTD Daniell Richard • Officer • Exec. VP, European Commercial Equity Compensation 2025-12-09 $2,124,542Largex4 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Daniell Richard Officer • Exec. VP, European Commercial Equity Compensation	2025-12-09	$2,124,542Largex4	M	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Daniell Richard • Officer • Exec. VP, European Commercial Discretionary SellΔOwn -70.5% 2025-12-09 $3,311,126Large View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Daniell Richard Officer • Exec. VP, European Commercial Discretionary SellΔOwn -70.5%	2025-12-09	$3,311,126Large	S	Form 4